Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950135-00-001849
Filing Date
2000-03-30
Accepted
2000-03-30 00:00:00
Documents
4
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 AQUILA BIOPHARMACEUTICALS, INC. 10-K405 175519
2 COMPUTATION OF EARNINGS PER SHARE EX-11 2728
3 CONSENT OF PWC EX-23 783
4 FINANCIAL DATA SCHEDULE EX-27 1985
  Complete submission text file 0000950135-00-001849.txt   183001
Mailing Address 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address 175 CROSSING BLVD BIOTECHNOLOGY RESEARCH PARK FRAMINGHAM MA 01702 5087975777
AQUILA BIOPHARMACEUTICALS INC (Filer) CIK: 0000704292 (see all company filings)

EIN.: 043307818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-12081 | Film No.: 587147
SIC: 2835 In Vitro & In Vivo Diagnostic Substances